Creative Planning - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 131 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
Creative Planning ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$641,034
+31.9%
16,781
+24.6%
0.00%0.0%
Q2 2023$485,863
+77.0%
13,470
+179.2%
0.00%
Q4 2022$274,486
+44.5%
4,824
-54.9%
0.00%
-100.0%
Q4 2019$190,000
-63.7%
10,692
-68.3%
0.00%
-50.0%
Q3 2019$523,000
-9.7%
33,6920.0%0.00%0.0%
Q2 2019$579,000
-7.1%
33,692
-12.9%
0.00%0.0%
Q1 2019$623,000
-32.6%
38,692
-38.8%
0.00%
-50.0%
Q4 2018$924,000
-20.3%
63,192
-0.9%
0.00%0.0%
Q3 2018$1,159,000
-6.9%
63,792
-13.6%
0.00%
-20.0%
Q2 2018$1,245,000
-25.0%
73,792
-13.0%
0.01%
-28.6%
Q1 2018$1,661,000
-6.5%
84,792
-3.3%
0.01%
-12.5%
Q4 2017$1,776,000
+14.7%
87,682
-1.6%
0.01%
+14.3%
Q3 2017$1,548,000
+5.3%
89,092
-22.3%
0.01%0.0%
Q2 2017$1,470,000
+0.1%
114,667
+1.2%
0.01%
-12.5%
Q1 2017$1,468,000
+40.2%
113,284
-16.5%
0.01%
+33.3%
Q4 2016$1,047,000
-16.4%
135,750
+1.9%
0.01%
-25.0%
Q3 2016$1,253,000
+5.4%
133,250
-20.4%
0.01%
-11.1%
Q2 2016$1,189,000
-18.1%
167,350
-8.2%
0.01%
-18.2%
Q1 2016$1,451,000
-42.9%
182,350
+3.4%
0.01%
-45.0%
Q4 2015$2,542,000
+38.8%
176,350
+4.8%
0.02%
+25.0%
Q3 2015$1,832,000
-37.6%
168,350
+20.0%
0.02%
-40.7%
Q2 2015$2,934,000
+560.8%
140,350
+351.3%
0.03%
+575.0%
Q1 2015$444,000
+43.2%
31,100
-3.1%
0.00%
+33.3%
Q4 2014$310,000
-44.7%
32,100
-47.9%
0.00%
-57.1%
Q3 2014$561,000
-6.7%
61,600
+1.3%
0.01%
-12.5%
Q2 2014$601,000
-20.6%
60,800
+2.0%
0.01%
-27.3%
Q1 2014$757,000
-15.7%
59,600
-0.5%
0.01%
-26.7%
Q4 2013$898,000
+164.1%
59,900
+94.5%
0.02%
+114.3%
Q3 2013$340,000
+38.8%
30,8000.0%0.01%
+16.7%
Q2 2013$245,00030,8000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$51,293,0007.24%
First Light Asset Management, LLC 2,050,273$93,103,0005.59%
TRAN CAPITAL MANAGEMENT, L.P. 1,350,870$61,343,0005.06%
SNYDER CAPITAL MANAGEMENT L P 3,176,404$144,241,0004.04%
DOHENY ASSET MANAGEMENT /CA 91,930$4,175,0002.69%
Redwood Investments, LLC 538,656$24,460,0001.97%
HighMark Wealth Management LLC 53,457$2,427,0001.78%
Taylor Wealth Management Partners 85,409$3,878,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 66,673$3,028,0001.35%
Granite Investment Partners, LLC 919,029$41,733,0001.29%
View complete list of HALOZYME THERAPEUTICS INC shareholders